-
Spec Money Rushes Back Into Small Caps
Tuesday, July 27, 2010 - 2:20pm | 173Speculative money has started to flow back into the market. After months of the small caps being dead and money flowing out of them, they have started to turn the corner higher. Most small cap and micro cap stocks have declined over 50% off their highs, finding their ways to lows. Finally, over...
-
Thermo Fisher Scientific Shares Diving On Lower Revenue Outlook (TMO)
Tuesday, July 27, 2010 - 1:31pm | 61Shares of Thermo Fisher Scientific Inc. (NYSE: TMO) are getting hit hard today after the company cut its revenue forecast and was very cautious on its revenue growth. Thermo Fisher cut its full-year revenue expectations by about $50 million due to foreign currency exchange rates issues. Shares of...
-
A Peek Into The Market At The Start Of The Trading Day
Tuesday, July 27, 2010 - 9:49am | 421Pre-open movers US stock index futures rose sharply today as strong results by several companies boosted market sentiments. While futures on the Dow Jones Industrial Average climbed 53 points to 10510, those on the S&P 500 added 6 points to 1115.50. Meanwhile, Nasdaq 100 futures moved up 9.25...
-
Benzinga’s Top Pre-Market NASDAQ Losers (QGEN, ERIC, ASML, AMZN)
Monday, July 26, 2010 - 8:37am | 150Qiagen NV (NASDAQ: QGEN) dipped 1.68% to $18.71 in the pre-market session. With the company losing 3.25% on Friday, QGEN is the top company in the Sciences Tools & Services industry in terms of relative performance. LM Ericsson Telephone Company (NASDAQ: ERIC) lost 1.51% to $11.11 in the pre-...
-
Good News for MannKind - Analyst Blog
Friday, July 23, 2010 - 6:06pm | 453MannKind Corporation (MNKD) received a boost when the US Food and Drug Administration (FDA) accepted MannKind’s response to the complete response letter (CRL) issued by the agency on its inhaled insulin candidate, Afrezza. The candidate is being developed for treating type I and type II diabetes...
-
Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG)
Friday, July 23, 2010 - 3:18pm | 97The Top 10 percentage gainers on the New York Stock Exchange as of 3:00 p.m. (This only includes companies which have traded at least 100,000 shares). Devry (NYSE: DV) is rising 14.11%. SEACOR Holdings Inc. (NYSE: CKH) is rising 12.16% Enzo Biochem, Inc. (NYSE: ENZ) is rising 9.7% Lithia Motors,...
-
J.P.Morgan Reduces Price Target on Affymetrix (AFFX)
Thursday, July 22, 2010 - 12:06pm | 163J.P.Morgan published a note this morning, where analysts reiterated its “neutral” rating on shares of Affymetrix (AFFX); and lowered its price target to $6.00 from $8.00. For 2Q, AFFX produced weak instrument sales due to delays in capital equipment purchasing in Europe, while consumables were also...
-
Good News for MannKind - Analyst Blog
Wednesday, July 21, 2010 - 2:42pm | 520MannKind Corp. (MNKD) received a boost when the US Food and Drug Administration (FDA) accepted MannKind’s response to the complete response letter (CRL) issued by the agency on its inhaled insulin candidate, Afrezza. The candidate is being developed for treating type I and type II diabetes. The...
-
Benzinga’s Top Pre-Market NASDAQ Gainers (SQNM, AAPL, CRUS, RYAAY)
Wednesday, July 21, 2010 - 8:57am | 137Sequenom Inc (NASDAQ: SQNM) rose 5.45% to $6 in the pre-market session. Analysts at Jefferies initiated coverage of SQNM with a “hold” rating. Apple Inc (NASDAQ: AAPL) added 3.73% to $261.29 in pre-market trading. AAPL has reported better-than-expected Q3 earnings due to a strong rise in the demand...
-
Pharma and Biotech Industry Outlook - July 2010 - Zacks Analyst Interviews
Wednesday, July 21, 2010 - 8:20am | 1848The pharmaceutical industry has witnessed major changes over the past few quarters, with performance being affected by factors like sluggish prescription trends, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance...
-
Pharma and Biotech Industry Outlook - July 2010 - Industry Outlook
Wednesday, July 21, 2010 - 8:20am | 1848The pharmaceutical industry has witnessed major changes over the past few quarters, with performance being affected by factors like sluggish prescription trends, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance...
-
Pharma and Biotech Industry Outlook - July 2010 - Industry Outlook
Tuesday, July 20, 2010 - 5:45pm | 1848The pharmaceutical industry has witnessed major changes over the past few quarters, with performance being affected by factors like sluggish prescription trends, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance...
-
JANA Partners Addresses Charles River's Latest Defense of Proposed WuXi Acquisition (CRL, WX)
Friday, July 16, 2010 - 9:46am | 65JANA Partners LLC today sent Charles River Laboratories International, Inc. (NYSE: CRL) a detailed critique of Charles River's revised investor presentation released earlier this week, in which Charles River once again seeks to persuade shareholders of the merits of its proposed acquisition of...
-
SPX Breaks Key 1085 Resistance 07-13-2010
Tuesday, July 13, 2010 - 3:34pm | 936Cusick’s Corner The market likes what it hears from positive beats on the earnings front (AA beat by a penny) and from a positive bond offering in Greece. We have also broken key overhead resistance, 1085 on the SPX, so now we need to keep an eye on these levels and watch the headlines to see if we...
-
Stocks Hitting 52-Week Highs (ABII, ADCT, BRCM, ERES)
Tuesday, July 13, 2010 - 1:23pm | 184Abraxis Bioscience Inc (NASDAQ: ABII) shares made a new high of $75.07, before slipping to $74.93, reflecting a gain of 0.17%. Within 24 hours of Celgene announcing its $2.9 billion offer for ABII, an investor has filed a lawsuit against Abraxis, alleging breach of fiduciary duty by some board of...